OvaScience does Not Expect to Meet 2015 Goal of 1,000 AUGMENTSM Treatment Cycles

By: via Benzinga
OvaScienceSM (NASDAQ: OVAS) today announced that the Company does not expect to meet the 2015 goal of 1,000 AUGMENTSM ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.